Sanofi: Q3 2012 Business EPS(1) reflects patent expirations

Sanofi: Q3 2012 Business EPS(1) reflects patent expirations The injunction against sales of PetArmor® Plus remains in effect and the generic product is not on the market. Third-quarter sales of the Production Animals segment were EUR 189 million, up 5.1%, … Continue reading

Posted in Pet Care Media | Tagged , , , , , , | Leave a comment